رجوع
80
18
مُدرج أيضًا باسم
ALPMY
OTC
نطاق اليوم
KWD 15.80
KWD 16.80
نطاق 52 أسبوعًا
KWD 8.40
KWD 17.39
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 15.05
/
KWD 12.11
الإغلاق السابق
KWD 16.15
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.6 | 0.3 |
| P/B | 0.0 | 2.9 |
| ROE % | 3.3 | 3.7 |
| Net Margin % | 2.7 | 3.8 |
| Rev Growth 5Y % | 11.2 | 10.0 |
| D/E | 0.6 | 0.2 |
النقاط الرئيسية
Revenue grew 11.23% annually over 5 years — strong growth
Earnings grew 197.72% over the past year
ROE of 3.26% is below average
Generating 137.18B in free cash flow
P/E of 0.59 — trading at a low valuation
PEG of 0.26 suggests growth is underpriced
النمو
Revenue Growth (5Y)
11.23%
Revenue (1Y)19.25%
Earnings (1Y)197.72%
FCF Growth (3Y)-24.27%
الجودة
Return on Equity
3.26%
ROIC1.31%
Net Margin2.65%
Op. Margin2.15%
الأمان
Debt / Equity
0.55
Current Ratio1.13
Interest Coverage2.32
التقييم
P/E Ratio
0.59
P/B Ratio0.02
EV/EBITDA16.40
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.25% | Revenue Growth (3Y) | 12.22% |
| Earnings Growth (1Y) | 197.72% | Earnings Growth (3Y) | -28.30% |
| Revenue Growth (5Y) | 11.23% | Earnings Growth (5Y) | -19.46% |
| Profitability | |||
| Revenue (TTM) | 1.91T | Net Income (TTM) | 50.75B |
| ROE | 3.26% | ROA | 1.52% |
| Gross Margin | 81.74% | Operating Margin | 2.15% |
| Net Margin | 2.65% | Free Cash Flow (TTM) | 137.18B |
| ROIC | 1.31% | FCF Growth (3Y) | -24.27% |
| Safety | |||
| Debt / Equity | 0.55 | Current Ratio | 1.13 |
| Interest Coverage | 2.32 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 0.59 | P/B Ratio | 0.02 |
| P/S Ratio | 0.02 | PEG Ratio | 0.26 |
| EV/EBITDA | 16.40 | Dividend Yield | 0.05% |
| Market Cap | 30.10B | Enterprise Value | 673.15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.91T | 1.60T | 1.52T | 1.30T | 1.25T |
| Net Income | 50.75B | 17.05B | 98.71B | 124.09B | 120.59B |
| EPS (Diluted) | 28.24 | 9.47 | 54.09 | 67.05 | 64.90 |
| Gross Profit | 1.56T | 1.31T | 1.23T | 1.04T | 1.00T |
| Operating Income | 41.04B | 25.52B | 133.03B | 220.02B | 136.05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.34T | 3.57T | 2.46T | 2.33T | 2.27T |
| Total Liabilities | 1.83T | 1.97T | 948.56B | 872.09B | 887.51B |
| Shareholders' Equity | 1.51T | 1.60T | 1.51T | 1.46T | 1.39T |
| Total Debt | 831.43B | 1.01T | 200.01B | 212.74B | 278.26B |
| Cash & Equivalents | 188.37B | 335.69B | 376.84B | 315.99B | 326.13B |
| Current Assets | 1.20T | 1.19T | 1.05T | 923.35B | 872.59B |
| Current Liabilities | 1.06T | 1.29T | 726.03B | 687.41B | 592.37B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#33 of 1052
#478 of 618
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026